The treatment of Psoriasis (product) as developed by Corbanix and its subsidiary is NOT A MEDICINAL PRODUCT but a Research in Progress. This product is NOT OFFERED FOR SALES anywhere in the world. Neither does the information provided in this website an offer nor invitation/solicitation for sales. This product is yet to go through numerous stages of research and development as well as the various phases of clinical evaluations and licensing processes before it can be offered for treatment.
This web site contains “forward-looking statements,” including statements about the Company’s growth, future operating results, discovery and development of products, strategic alliances and intellectual property. Forward-looking statements include statements concerning our plans, objectives, goals, strategies, future events, future revenues or performance, capital expenditures, compensation arrangements, financing needs, plans or intentions relating to acquisitions, business trends and other information that is not historical information. Various important risks may cause the Company’s actual results to differ materially from the results indicated by these forward-looking statements, including: adverse results in its drug discovery, pre-clinical and clinical development programs; failure to obtain grants; failure to obtain patent protection for its discoveries; commercial limitations imposed by patents owned or controlled by third parties; difficulties or delays in obtaining regulatory approvals to market products and services resulting from the Company’s development efforts; product withdrawals; competitive factors; difficulties or delays in commercialization of Company’s products; and the requirement for substantial funding to conduct research and development and to expand commercialization activities.
Thank you for your interest and support.